CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene

Nucleotide excision repair: Why is it not used to predict response to platinum-based chemotherapy?

(2014) Nikola A. Bowden   CANCER LETTERS

ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy

(2013) Sara De Dosso et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Kdm4b Histone Demethylase Is a DNA Damage Response Protein and Confers a Survival Advantage following γ-Irradiation

(2013) Leah C. Young et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Selective Inhibition of p300 HAT Blocks Cell Cycle Progression, Induces Cellular Senescence, and Inhibits the DNA Damage Response in Melanoma Cells

(2013) Gai Yan et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Golgi-SNARE GS28 potentiates cisplatin-induced apoptosis by forming GS28–MDM2–p53 complexes and by preventing the ubiquitination and degradation of p53

(2012) Nian-Kang Sun et al.   BIOCHEMICAL JOURNAL

p38 mitogen-activated protein kinase signaling, ERCC1 expression, and viability of lung cancer cells from never or light smoker patients

(2012) David Planchard et al.   CANCER

DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis

(2012) Wynand P. Roos et al.   CANCER LETTERS

Latent membrane protein 1 of Epstein–Barr virus sensitizes cancer cells to cisplatin by enhancing NF-κB p50 homodimer formation and downregulating NAPA expression

(2011) Zchong-Zcho Wu et al.   BIOCHEMICAL PHARMACOLOGY

Protein Conformation and Supercharging with DMSO from Aqueous Solution

(2011) Harry J. Sterling et al.   JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY

Chromatin and the DNA damage response: The cancer connection

(2011) Martijn S. Luijsterburg et al.   Molecular Oncology

Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition

(2011) Oliver G McDonald et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

γH2Ax: Biomarker of Damage or Functional Participant in DNA Repair “All that Glitters Is not Gold!”

(2011) James E. Cleaver   PHOTOCHEMISTRY AND PHOTOBIOLOGY

Knockdown of NAPA using short-hairpin RNA sensitizes cancer cells to cisplatin: Implications to overcome chemoresistance

(2010) Zchong-Zcho Wu et al.   BIOCHEMICAL PHARMACOLOGY

Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells

(2010) Zchong-Zcho Wu et al.   BIOCHEMICAL PHARMACOLOGY

Downregulation of XPF–ERCC1 enhances cisplatin efficacy in cancer cells☆

(2010) Sanjeevani Arora et al.   DNA REPAIR

Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis

(2010) Zchong-Zcho Wu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis

(2010) Sufeng Chen et al.   LUNG CANCER

Pifithrin-α protects against DNA damage-induced apoptosis downstream of mitochondria independent of p53

(2009) D Sohn et al.   CELL DEATH AND DIFFERENTIATION

Screen for DNA-damage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells

(2009) Jorrit V Tjeertes et al.   EMBO JOURNAL

Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer

(2009) Craig Reynolds et al.   JOURNAL OF CLINICAL ONCOLOGY

The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links

(2009) A. Z. Al-Minawi et al.   NUCLEIC ACIDS RESEARCH

Role for DYRK family kinases on regulation of apoptosis

(2008) Kiyotsugu Yoshida   BIOCHEMICAL PHARMACOLOGY

Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy

(2008) P.H. Clingen et al.   BIOCHEMICAL PHARMACOLOGY

Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro

(2008) Hironobu Yanagie et al.   BIOMEDICINE & PHARMACOTHERAPY

CITED2 Signals through Peroxisome Proliferator-Activated Receptor-  to Regulate Death of Cortical Neurons after DNA Damage

(2008) Y. R. Gonzalez et al.   JOURNAL OF NEUROSCIENCE

Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?

(2008) Daniel T. Bergstralh et al.   TRENDS IN GENETICS